Russell SJ, Peng KW, Bell JC. Oncolytic virotherapy. Nat Biotechnol. 2012;30(7):658–70.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kirn D, Martuza RL, Zwiebel J. Replication-selective virotherapy for cancer: Biological principles, risk management and future directions. Nat Med. 2001;7(7):781–7.
Article
CAS
PubMed
Google Scholar
Yu W, Fang H. Clinical trials with oncolytic adenovirus in China. Curr Cancer Drug Targets. 2007;7(2):141–8.
Article
PubMed
Google Scholar
Kruyt FA, Curiel DT. Toward a new generation of conditionally replicating adenoviruses: pairing tumor selectivity with maximal oncolysis. Hum Gene Ther. 2002;13(4):485–95.
Article
CAS
PubMed
Google Scholar
Zhu ZB, Makhija SK, Lu B, Wang M, Rivera AA, Kim-Park S, et al. Incorporating the survivin promoter in an infectivity enhanced CRAd-analysis of oncolysis and anti-tumor effects in vitro and in vivo. Int J Oncol. 2005;27(1):237–46.
Wang H, Wei F, Zhang J, Wang F, Li H, Chen X, et al. A novel immunocompetent murine tumor model for the evaluation of RCAd-enhanced RDAd transduction efficacy. Tumour Biol. 2012;33(4):1245–53.
Wang Y, Hallden G, Hill R, Anand A, Liu TC, Francis J, et al. E3 gene manipulations affect oncolytic adenovirus activity in immunocompetent tumor models. Nat Biotechnol. 2003;21(11):1328–35.
Wold WS, Hermiston TW, Tollefson AE. Adenovirus proteins that subvert host defenses. Trends Microbiol. 1994;2(11):437–43.
Article
CAS
PubMed
Google Scholar
Hallden G, Hill R, Wang Y, Anand A, Liu TC, Lemoine NR, et al. Novel immunocompetent murine tumor models for the assessment of replication-competent oncolytic adenovirus efficacy. Mol Ther. 2003;8(3):412–24.
Ungerechts G, Springfeld C, Frenzke ME, Lampe J, Parker WB, Sorscher EJ, et al. An immunocompetent murine model for oncolysis with an armed and targeted measles virus. Mol Ther. 2007;15(11):1991–7.
Bischoff JR, Kirn DH, Williams A, Heise C, Horn S, Muna M, et al. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science. 1996;274(5286):373–6.
Rogulski KR, Freytag SO, Zhang K, Gilbert JD, Paielli DL, Kim JH, et al. In vivo antitumor activity of ONYX-015 is influenced by p53 status and is augmented by radiotherapy. Cancer Res. 2000;60(5):1193–6.
Dix BR, Edwards SJ, Braithwaite AW. Does the antitumor adenovirus ONYX-015/dl1520 selectively target cells defective in the p53 pathway? J Virol. 2001;75(12):5443–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Goodrum FD, Ornelles DA. p53 status does not determine outcome of E1B 55-kilodalton mutant adenovirus lytic infection. J Virol. 1998;72(12):9479–90.
CAS
PubMed
PubMed Central
Google Scholar
Geoerger B, Grill J, Opolon P, Morizet J, Aubert G, Terrier-Lacombe MJ, et al. Oncolytic activity of the E1B-55 kDa-deleted adenovirus ONYX-015 is independent of cellular p53 status in human malignant glioma xenografts. Cancer Res. 2002;62(3):764–72.
Rothmann T, Hengstermann A, Whitaker NJ, Scheffner M, zur Hausen H. Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells. J Virol. 1998;72(12):9470–8.
CAS
PubMed
PubMed Central
Google Scholar
Zheng X, Rao XM, Gomez-Gutierrez JG, Hao H, McMasters KM, Zhou HS. Adenovirus E1B55K region is required to enhance cyclin E expression for efficient viral DNA replication. J Virol. 2008;82(7):3415–27.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rao XM, Zheng X, Waigel S, Zacharias W, McMasters KM, Zhou HS. Gene expression profiles of normal human lung cells affected by adenoviral E1B. Virology. 2006;350(2):418–28.
Article
CAS
PubMed
Google Scholar
Cheng PH, Rao XM, McMasters KM, Zhou HS. Molecular basis for viral selective replication in cancer cells: activation of CDK2 by adenovirus-induced cyclin E. PLoS One. 2013;8(2):e57340.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM, Pagano M. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol. 1995;15(5):2612–24.
Article
CAS
PubMed
PubMed Central
Google Scholar
Coverley D, Laman H, Laskey RA. Distinct roles for cyclins E and A during DNA replication complex assembly and activation. Nat Cell Biol. 2002;4(7):523–8.
Article
CAS
PubMed
Google Scholar
Furstenthal L, Kaiser BK, Swanson C, Jackson PK. Cyclin E uses Cdc6 as a chromatin-associated receptor required for DNA replication. J Cell Biol. 2001;152(6):1267–78.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hinchcliffe EH, Li C, Thompson EA, Maller JL, Sluder G. Requirement of Cdk2-cyclin E activity for repeated centrosome reproduction in Xenopus egg extracts. Science. 1999;283(5403):851–4.
Article
CAS
PubMed
Google Scholar
Matsumoto Y, Hayashi K, Nishida E. Cyclin-dependent kinase 2 (Cdk2) is required for centrosome duplication in mammalian cells. Curr Biol. 1999;9(8):429–32.
Article
CAS
PubMed
Google Scholar
Donnellan R, Chetty R. Cyclin E in human cancers. FASEB J. 1999;13(8):773–80.
CAS
PubMed
Google Scholar
Malumbres M, Barbacid M. To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer. 2001;1(3):222–31.
Article
CAS
PubMed
Google Scholar
Spruck CH, Won KA, Reed SI. Deregulated cyclin E induces chromosome instability. Nature. 1999;401(6750):297–300.
Article
CAS
PubMed
Google Scholar
Minella AC, Swanger J, Bryant E, Welcker M, Hwang H, Clurman BE. p53 and p21 form an inducible barrier that protects cells against cyclin E-cdk2 deregulation. Curr Biol. 2002;12(21):1817–27.
Article
CAS
PubMed
Google Scholar
Bortner DM, Rosenberg MP. Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E. Mol Cell Biol. 1997;17(1):453–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Loeb KR, Kostner H, Firpo E, Norwood T, Tsuchiya K D, Clurman BE, et al. A mouse model for cyclin E-dependent genetic instability and tumorigenesis. Cancer Cell. 2005;8(1):35–47.
Freemantle SJ, Dmitrovsky E. Cyclin E transgenic mice: discovery tools for lung cancer biology, therapy, and prevention. Cancer Prev Res (Phila). 2010;3(12):1513–8.
Article
Google Scholar
Ma Y, Fiering S, Black C, Liu X, Yuan Z, Memoli VA, et al. Transgenic cyclin E triggers dysplasia and multiple pulmonary adenocarcinomas. Proc Natl Acad Sci U S A. 2007;104(10):4089–94.
Liu X, Sempere LF, Galimberti F, Freemantle SJ, Black C, Dragnev KH, et al. Uncovering growth-suppressive MicroRNAs in lung cancer. Clin Canc Res. 2009;15(4):1177–83.
Cheng PH, Rao XM, Duan X, Li XF, Egger ME, McMasters KM, Zhou HS. Virotherapy targeting cyclin E overexpression in tumors with adenovirus-enhanced cancer-selective promoter. J Mol Med (Berl). 2015;93(2):211–23.
Article
CAS
Google Scholar
Barker DD, Berk AJ. Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection. Virology. 1987;156(1):107–21.
Article
CAS
PubMed
Google Scholar
Rodriguez-Rocha H, Gomez-Gutierrez JG, Garcia-Garcia A, Rao XM, Chen L, McMasters KM, et al. Adenoviruses induce autophagy to promote virus replication and oncolysis. Virology. 2011;416(1–2):9–15.
Fan W, Lin CS, Potluri P, Procaccio V, Wallace DC. mtDNA lineage analysis of mouse L-cell lines reveals the accumulation of multiple mtDNA mutants and intermolecular recombination. Genes Dev. 2012;26(4):384–94.
Article
CAS
PubMed
PubMed Central
Google Scholar
Widera D, Zander C, Heidbreder M, Kasperek Y, Noll T, Seitz O, et al. Adult palatum as a novel source of neural crest-related stem cells. Stem Cells. 2009;27(8):1899–910.
Cheng PH, Lian S, Zhao R, Rao XM, McMasters KM, Zhou HS. Combination of autophagy inducer rapamycin and oncolytic adenovirus improves antitumor effect in cancer cells. Virol J. 2013;10(1):293.
Article
PubMed
PubMed Central
Google Scholar
Kwon OJ, Kim PH, Huyn S, Wu L, Kim M, Yun CO. A hypoxia- and {alpha}-fetoprotein-dependent oncolytic adenovirus exhibits specific killing of hepatocellular carcinomas. Clin Canc Res. 2010;16(24):6071–82.
Article
CAS
Google Scholar
Nguyen MD, Lariviere RC, Julien JP. Reduction of axonal caliber does not alleviate motor neuron disease caused by mutant superoxide dismutase 1. Proc Natl Acad Sci U S A. 2000;97(22):12306–11.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zheng X, Rao XM, Snodgrass CL, McMasters KM, Zhou HS. Selective replication of E1B55K-deleted adenoviruses depends on enhanced E1A expression in cancer cells. Cancer Gene Ther. 2006;13(6):572–83.
Article
CAS
PubMed
Google Scholar
Sandig V, Youil R, Bett AJ, Franlin LL, Oshima M, Maione D, et al. Optimization of the helper-dependent adenovirus system for production and potency in vivo. Proc Natl Acad Sci U S A. 2000;97(3):1002–7.
Zhao T, Rao XM, Xie X, Li L, Thompson TC, McMasters KM, et al. Adenovirus with insertion-mutated E1A selectively propagates in liver cancer cells and destroys tumors in vivo. Cancer Res. 2003;63(12):3073–8.
Ganly I, Kim YT, Hann B, Balmain A, Brown R. Replication and cytolysis of an E1B-attenuated adenovirus in drug-resistant ovarian tumour cells is associated with reduced apoptosis. Gene Ther. 2001;8(5):369–75.
Article
CAS
PubMed
Google Scholar
Ganly I, Mautner V, Balmain A. Productive replication of human adenoviruses in mouse epidermal cells. J Virol. 2000;74(6):2895–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Madara J, Krewet JA, Shah M. Heat shock protein 72 expression allows permissive replication of oncolytic adenovirus dl1520 (ONYX-015) in rat glioblastoma cells. Mol Cancer. 2005;4(1):12.
Article
PubMed
PubMed Central
Google Scholar
Huang T, Civelek AC, Zheng H, Ng CK, Duan X, Li J, et al. (18)F-misonidazole PET imaging of hypoxia in micrometastases and macroscopic xenografts of human non-small cell lung cancer: a correlation with autoradiography and histological findings. Am J Nucl Med Mol Imag. 2013;3(2):142–53.
Todaro GJ, Green H. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J Cell Biol. 1963;17:299–313.
Article
CAS
PubMed
PubMed Central
Google Scholar
Glasser SW, Korfhagen TR, Wert SE, Bruno MD, McWilliams KM, Vorbroker DK, et al. Genetic element from human surfactant protein SP-C gene confers bronchiolar-alveolar cell specificity in transgenic mice. Am J Physiol. 1991;261(4 Pt 1):L349–56.
Degryse E, De Santi MM, Dietrich M, Hadji DA, Spetz JF, Villeval D, et al. A human SP-C promoter fragment targets alpha 1-proteinase inhibitor gene expression to lung alveolar type II cells in transgenic mice. Transgenic Res. 1996;5(2):139–43.
Glasser SW, Eszterhas SK, Detmer EA, Maxfield MD, Korfhagen TR. The murine SP-C promoter directs type II cell-specific expression in transgenic mice. Am J Physiol Lung Cell Mol Physiol. 2005;288(4):L625–32.
Article
CAS
PubMed
Google Scholar
Kerkhoff E, Fedorov LM, Siefken R, Walter AO, Papadopoulos T, Rapp UR. Lung-targeted expression of the c-Raf-1 kinase in transgenic mice exposes a novel oncogenic character of the wild-type protein. Cell Growth Differ. 2000;11(4):185–90.
CAS
PubMed
Google Scholar
Whitsett JA, Glasser SW. Regulation of surfactant protein gene transcription. Biochim Biophys Acta. 1998;1408(2–3):303–11.
Article
CAS
PubMed
Google Scholar
Wadler S, Yu B, Tan JY, Kaleya R, Rozenblit A, Makower D, et al. Persistent replication of the modified chimeric adenovirus ONYX-015 in both tumor and stromal cells from a patient with gall bladder carcinoma implants. Clin Canc Res. 2003;9(1):33–43.
Oualikene W, Gonin P, Eloit M. Short and long term dissemination of deletion mutants of adenovirus in permissive (cotton rat) and non-permissive (mouse) species. J Gen Virol. 1994;75(Pt 10):2765–8.
Article
CAS
PubMed
Google Scholar
Tomko RP, Xu R, Philipson L. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci U S A. 1997;94(7):3352–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Duncan SJ, Gordon FC, Gregory DW, McPhie JL, Postlethwaite R, White R, et al. Infection of mouse liver by human adenovirus type 5. J Gen Virol. 1978;40(1):45–61.
Biron KK, Raska Jr K. Adenovirus type 12 infection of defined mouse-human hybrid cell clones. Experientia. 1976;32(1):38–40.
Article
CAS
PubMed
Google Scholar
Eggerding FA, Pierce WC. Molecular biology of adenovirus type 2 semipermissive infections. I. Viral growth and expression of viral replicative functions during restricted adenovirus infection. Virology. 1986;148(1):97–113.
Article
CAS
PubMed
Google Scholar
Blair GE, Dixon SC, Griffiths SA, Zajdel ME. Restricted replication of human adenovirus type 5 in mouse cell lines. Virus Res. 1989;14(4):339–46.
Article
CAS
PubMed
Google Scholar
Lucher LA. Abortive adenovirus infection and host range determinants. Curr Top Microbiol Immunol. 1995;199(Pt 1):119–52.
CAS
PubMed
Google Scholar
Seth P, Rosenfeld M, Higginbotham J, Crystal RG. Mechanism of enhancement of DNA expression consequent to cointernalization of a replication-deficient adenovirus and unmodified plasmid DNA. J Virol. 1994;68(2):933–40.
CAS
PubMed
PubMed Central
Google Scholar
Silverstein G, Strohl WA. Restricted replication of adenovirus type 2 in mouse Balb/3T3 cells. Arch Virol. 1986;87(3–4):241–64.
Ashraf S, Hompes R, Slater A, Lindsey I, Bach S, Mortensen NJ, et al. A critical appraisal of endorectal ultrasound and transanal endoscopic microsurgery and decision-making in early rectal cancer. Colorectal Dis. 2012;14(7):821–6.
Zhang H. Life without kinase: cyclin E promotes DNA replication licensing and beyond. Mol Cell. 2007;25(2):175–6.
Article
CAS
PubMed
Google Scholar
Hwang HC, Clurman BE. Cyclin E in normal and neoplastic cell cycles. Oncogene. 2005;24(17):2776–86.
Article
CAS
PubMed
Google Scholar
Galanis E, Okuno SH, Nascimento AG, Lewis BD, Lee RA, Oliveira AM, et al. Phase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas. Gene Ther. 2005;12(5):437–45.
Parato KA, Senger D, Forsyth PA, Bell JC. Recent progress in the battle between oncolytic viruses and tumours. Nat Rev Cancer. 2005;5(12):965–76.
Article
CAS
PubMed
Google Scholar
Smith E, Breznik J, Lichty BD. Strategies to enhance viral penetration of solid tumors. Hum Gene Ther. 2011;22(9):1053–60.
Article
CAS
PubMed
Google Scholar
Guedan S, Rojas JJ, Gros A, Mercade E, Cascallo M, Alemany R. Hyaluronidase expression by an oncolytic adenovirus enhances its intratumoral spread and suppresses tumor growth. Mol Ther. 2010;18(7):1275–83.
Article
CAS
PubMed
PubMed Central
Google Scholar
Naik JD, Twelves CJ, Selby PJ, Vile RG, Chester JD. Immune recruitment and therapeutic synergy: keys to optimizing oncolytic viral therapy? Clin Canc Res. 2011;17(13):4214–24.
Article
CAS
Google Scholar
Mullen JT, Tanabe KK. Viral oncolysis. Oncologist. 2002;7(2):106–19.
Article
CAS
PubMed
Google Scholar